Hepu Pharma

贺普药业

Hepu Pharma

Biotech/Healthcare

Hepu Pharmaceutical is a company focused on new drug R&D for hepatitis B, and was among the first batch of companies listed on the Science and Technology Innovation Board of the Shanghai Equity Exchange and Custody Center (share code 300011). It owns independent intellectual property rights to…

Latest round: Pre Series B (2022)

Source: ChinaBulls — chinabulls.com

Last updated 2022-07-01